TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Phase IIB Trial Evaluating Wound Complication Rate After Skin Closure With Staples Versus Subcuticular Suture in Patients With BMI >=30
Brief Summary: Women with gynecologic cancers are often obese and have other risk factors for post-operative wound separation. Data from obstetrics and orthopedic surgery literature have shown a decreased risk of wound separation and complications when the skin is closed with suture as compared to staples. Skin closure with either staples or suture is considered standard of care. Traditionally, most wounds have been closed with staples given their ease of use and quick application. In this randomized study the investigators plan to evaluate and compare the complication rate associated with both standard closures.


Options:
A: Intervention Type: DEVICE; Name: wound closure device (Steri-Strip™); Assigned to Arm(s): N/A
B: Arm Label: Stainless Steel Staples; Type: ACTIVE_COMPARATOR; Interventions: Device: Stainless steel staples | Arm Label: 4-0 monofilament Sutures; Type: EXPERIMENTAL; Interventions: Device: 4-0 monofilament suture | Intervention Type: DEVICE; Name: 4-0 monofilament suture; Assigned to Arm(s): 4-0 monofilament Sutures | Intervention Type: DEVICE; Name: Stainless steel staples; Assigned to Arm(s): Stainless Steel Staples
C: Arm Label: Continuous intradermic stitch; Type: EXPERIMENTAL; Interventions: Procedure: Continuous intradermic stitch | Arm Label: Separated stitches; Type: SHAM_COMPARATOR; Interventions: Procedure: Separated stitches | Intervention Type: PROCEDURE; Name: Continuous intradermic stitch; Assigned to Arm(s): Continuous intradermic stitch | Intervention Type: PROCEDURE; Name: Separated stitches; Assigned to Arm(s): Separated stitches
D: Arm Label: Interrupted suturing Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Interrupted suturing | Arm Label: Subcuticular suturing Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Subcuticular suturing | Intervention Type: OTHER; Name: Interrupted suturing; Assigned to Arm(s): Interrupted suturing Group | Intervention Type: OTHER; Name: Subcuticular suturing; Assigned to Arm(s): Subcuticular suturing Group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).
Brief Summary: We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.


Options:
A: Arm Label: Traditional ICD Programming; Type: ACTIVE_COMPARATOR; Interventions: Other: Traditional ICD Programming | Arm Label: Ultra Conservative ICD Programming; Type: EXPERIMENTAL; Interventions: Other: Ultra Conservative ICD Programming | Intervention Type: OTHER; Name: Ultra Conservative ICD Programming; Assigned to Arm(s): Ultra Conservative ICD Programming | Intervention Type: OTHER; Name: Traditional ICD Programming; Assigned to Arm(s): Traditional ICD Programming
B: Arm Label: Cohort A (longitudinal); Type: N/A; Interventions: N/A | Arm Label: Cohort B (6 Month); Type: N/A; Interventions: N/A | Arm Label: Cohort C (18 Month); Type: N/A; Interventions: N/A
C: Arm Label: 1. Optimal Medical therapy plus ICD; Type: ACTIVE_COMPARATOR; Interventions: Device: Optimal Medical Therapy plus ICD | Arm Label: 2. Optimal Medical Therapy plus CRT/ICD; Type: ACTIVE_COMPARATOR; Interventions: Device: Optimal Medical Therapy plus CRT/ICD | Intervention Type: DEVICE; Name: Optimal Medical Therapy plus ICD; Assigned to Arm(s): 1. Optimal Medical therapy plus ICD | Intervention Type: DEVICE; Name: Optimal Medical Therapy plus CRT/ICD; Assigned to Arm(s): 2. Optimal Medical Therapy plus CRT/ICD
D: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing in Vitro Fertilization Treatment
Brief Summary: Implantation failure remains one of the major factors limiting success in IVF treatment. It was postulated that the local injury to endometrium induces secretions of cytokines and growth factors such as leukemia inhibitory factor, interleukin-11, and heparin-binding EGF-like growth factor which enhance decidualisation and facilitate implantation. It may also up-regulate the gene expressions related to endometrial receptivity and optimize the endometrial development. In stimulated cycles, local injury to the proliferative endometrium has been postulated to delay endometrial development thereby inducing synchronicity between endometrium and embryo stage and facilitate implantation (Zhou et al, 2008; Almog et al, 2010; Gnainsky et al, 2010) The aim of the study is to determine whether endometrial injury by endometrial biopsy in mid-secretory phase of the preceding cycle would improve the on-going pregnancy rate in subfertile women undergoing IVF treatment.


Options:
A: Arm Label: Endometrial Aspirate (EA) group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial aspiration by pipelle | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial aspiration by pipelle; Assigned to Arm(s): Endometrial Aspirate (EA) group
B: Arm Label: group 1 : IVF with biopsy; Type: EXPERIMENTAL; Interventions: Procedure: biopsy | Arm Label: group 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: IVF | Intervention Type: PROCEDURE; Name: biopsy; Assigned to Arm(s): group 1 : IVF with biopsy | Intervention Type: PROCEDURE; Name: IVF; Assigned to Arm(s): group 2
C: Arm Label: Endometrial Injury; Type: ACTIVE_COMPARATOR; Interventions: Other: Endometrial Injury | Arm Label: Luteal Phase Support; Type: ACTIVE_COMPARATOR; Interventions: Drug: progesterone (Crinone® %8 vaginal progesterone gel) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Endometrial Injury; Assigned to Arm(s): Endometrial Injury | Intervention Type: DRUG; Name: progesterone (Crinone® %8 vaginal progesterone gel); Assigned to Arm(s): Luteal Phase Support
D: Arm Label: GROUP A: intervention group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial scratch | Arm Label: GROUP B: no intervention group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial scratch; Assigned to Arm(s): GROUP A: intervention group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MANAGE AT WORK: Evaluation of a Group-based Self-management Program to Address Workplace Discomfort and Fatigue Associated With Chronic Physical Health Conditions
Brief Summary: The specific aim of the study is to evaluate the health benefits of a series of group workshops designed for workers with chronic physical health conditions. The facilitated workshops apply principles of pain and illness self-management to help workers deal with health-related challenges while at work. The workshops address issues of pain management, physical job demands, pacing of work, communication, problem solving, and coping. Half of the participants in the study will be randomly assigned to attend workshop sessions (10 hours total), and all study participants will be followed for one year. The primary hypothesis is that workers who participate in these workshops will show improvements in work engagement and reductions in work limitation in the subsequent 12 months.


Options:
A: Arm Label: Arm 1: HOPE; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Outcomes through Patient Empowerment (HOPE) | Arm Label: Arm 2: EUC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Healthy Outcomes through Patient Empowerment (HOPE); Assigned to Arm(s): Arm 1: HOPE | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Arm 2: EUC
B: Arm Label: Diabetes-Specific CBT (DS-CBT); Type: EXPERIMENTAL; Interventions: Behavioral: Diabetes-Specific CBT (DS-CBT) | Arm Label: Standard Diabetes Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Diabetes Education | Intervention Type: BEHAVIORAL; Name: Diabetes-Specific CBT (DS-CBT); Assigned to Arm(s): Diabetes-Specific CBT (DS-CBT) | Intervention Type: BEHAVIORAL; Name: Standard Diabetes Education; Assigned to Arm(s): Standard Diabetes Education
C: Arm Label: regular medical care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: The CareWell programme; Type: EXPERIMENTAL; Interventions: Other: The CareWell programme | Intervention Type: OTHER; Name: The CareWell programme; Assigned to Arm(s): The CareWell programme
D: Arm Label: Self-management group workshops; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management group workshops | Arm Label: No treament (wait-list control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-management group workshops; Assigned to Arm(s): Self-management group workshops

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: MANAGE AT WORK: Evaluation of a Group-based Self-management Program to Address Workplace Discomfort and Fatigue Associated With Chronic Physical Health Conditions
Brief Summary: The specific aim of the study is to evaluate the health benefits of a series of group workshops designed for workers with chronic physical health conditions. The facilitated workshops apply principles of pain and illness self-management to help workers deal with health-related challenges while at work. The workshops address issues of pain management, physical job demands, pacing of work, communication, problem solving, and coping. Half of the participants in the study will be randomly assigned to attend workshop sessions (10 hours total), and all study participants will be followed for one year. The primary hypothesis is that workers who participate in these workshops will show improvements in work engagement and reductions in work limitation in the subsequent 12 months.


Options:
A: Arm Label: Conventional care, controlgroup; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: integrated health care chain; Type: EXPERIMENTAL; Interventions: Other: integrated health care chain | Intervention Type: OTHER; Name: integrated health care chain; Assigned to Arm(s): integrated health care chain
B: Arm Label: Self-management group workshops; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management group workshops | Arm Label: No treament (wait-list control); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-management group workshops; Assigned to Arm(s): Self-management group workshops
C: Arm Label: regular medical care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: The CareWell programme; Type: EXPERIMENTAL; Interventions: Other: The CareWell programme | Intervention Type: OTHER; Name: The CareWell programme; Assigned to Arm(s): The CareWell programme
D: Arm Label: Home Telemonitoring; Type: EXPERIMENTAL; Interventions: Device: Intel Health Guide | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: DEVICE; Name: Intel Health Guide; Assigned to Arm(s): Home Telemonitoring | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness Pharmaceutical Care at Discharge in the Emergency Department: a Randomized Controlled Trial
Brief Summary: The purpose of this study is to evaluate the effectiveness of pharmaceutical care, compared to usual care, in patient discharge in an emergency department in patients with hypertension and/or diabetes mellitus type 2.


Options:
A: Arm Label: NMS; Type: EXPERIMENTAL; Interventions: Other: New Medicine Service | Arm Label: Current Practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: New Medicine Service; Assigned to Arm(s): NMS
B: Arm Label: Pharmaceutical care; Type: EXPERIMENTAL; Interventions: Other: Pharmaceutical care | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Pharmaceutical care; Assigned to Arm(s): Pharmaceutical care
C: Arm Label: 1; Type: N/A; Interventions: Other: 1 | Arm Label: 2; Type: N/A; Interventions: Other: 2 | Intervention Type: OTHER; Name: 1; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: 2; Assigned to Arm(s): 2
D: Arm Label: Advice on DDIs; Type: EXPERIMENTAL; Interventions: Behavioral: Advice on DDIs | Arm Label: General advice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Advice on DDIs; Assigned to Arm(s): Advice on DDIs

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand (ESCORT Study)
Brief Summary: If primary health-care officers and Villages Health Volunteers (VHVs) be trained to render proper CKD care, it is interesting if their intimate relationship and commitment to their responsible village households will result in better outcomes when compared with the conventional care model as mention above. In this project, we plan to compare the effectiveness of a conventional care program against an integrated multidisciplinary CKD care program provided by nephrologists in conjunction with well-trained paramedical personnel and VHVs on CKD progression.


Options:
A: Arm Label: Best practices primary care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best practices primary care | Arm Label: Home based occupational therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Home based occupational therapy; Assigned to Arm(s): Home based occupational therapy | Intervention Type: BEHAVIORAL; Name: Best practices primary care; Assigned to Arm(s): Best practices primary care
B: Intervention Type: BEHAVIORAL; Name: UNITED Planned Care; Assigned to Arm(s): N/A
C: Arm Label: CALM Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral therapy, Drug: Psychotropic medication optimization | Arm Label: Treatment as Usual (TAU); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy; Assigned to Arm(s): CALM Intervention | Intervention Type: DRUG; Name: Psychotropic medication optimization; Assigned to Arm(s): CALM Intervention | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual (TAU)
D: Arm Label: Integrated Chronic Kidney Disease care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Chronic Kidney Disease care | Arm Label: Conventional CKD care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional CKD care | Intervention Type: BEHAVIORAL; Name: Integrated Chronic Kidney Disease care; Assigned to Arm(s): Integrated Chronic Kidney Disease care | Intervention Type: BEHAVIORAL; Name: Conventional CKD care; Assigned to Arm(s): Conventional CKD care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Integrated Care on Delaying Chronic Kidney Disease Progression in Rural Communities of Thailand (ESCORT Study)
Brief Summary: If primary health-care officers and Villages Health Volunteers (VHVs) be trained to render proper CKD care, it is interesting if their intimate relationship and commitment to their responsible village households will result in better outcomes when compared with the conventional care model as mention above. In this project, we plan to compare the effectiveness of a conventional care program against an integrated multidisciplinary CKD care program provided by nephrologists in conjunction with well-trained paramedical personnel and VHVs on CKD progression.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: iChoose Kidney Decision Aid; Type: EXPERIMENTAL; Interventions: Behavioral: iChoose Kidney Decision Aid | Intervention Type: BEHAVIORAL; Name: iChoose Kidney Decision Aid; Assigned to Arm(s): iChoose Kidney Decision Aid
B: Arm Label: Integrated Chronic Kidney Disease care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Chronic Kidney Disease care | Arm Label: Conventional CKD care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Conventional CKD care | Intervention Type: BEHAVIORAL; Name: Integrated Chronic Kidney Disease care; Assigned to Arm(s): Integrated Chronic Kidney Disease care | Intervention Type: BEHAVIORAL; Name: Conventional CKD care; Assigned to Arm(s): Conventional CKD care
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: automated clinical alerts, Other: provider education | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: provider education | Intervention Type: OTHER; Name: automated clinical alerts; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: provider education; Assigned to Arm(s): 1, 2
D: Arm Label: ATSM + Health Coach and CKD Registry; Type: EXPERIMENTAL; Interventions: Behavioral: CKD Registry, Behavioral: ATSM + Health Coach | Arm Label: CKD Registry; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CKD Registry | Arm Label: ATSM + Health Coach; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ATSM + Health Coach | Arm Label: Usual Care (no interventions); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: CKD Registry; Assigned to Arm(s): ATSM + Health Coach and CKD Registry, CKD Registry | Intervention Type: BEHAVIORAL; Name: ATSM + Health Coach; Assigned to Arm(s): ATSM + Health Coach, ATSM + Health Coach and CKD Registry | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual Care (no interventions)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Investigating the Efficacy, Safety, Serum Concentration and Biomarker Profile of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Brief Summary: The primary objective of the study was to assess the efficacy of Dupilumab, compared to placebo, in adult patients with moderate-to-severe atopic dermatitis (AD).


Options:
A: Arm Label: Group1; Type: EXPERIMENTAL; Interventions: Drug: nemolizumab (CIM331) | Arm Label: Group2; Type: EXPERIMENTAL; Interventions: Drug: nemolizumab (CIM331) | Arm Label: Group3; Type: EXPERIMENTAL; Interventions: Drug: nemolizumab (CIM331) | Arm Label: Group4; Type: EXPERIMENTAL; Interventions: Drug: nemolizumab (CIM331) | Arm Label: Group5; Type: EXPERIMENTAL; Interventions: Drug: nemolizumab (CIM331), Other: Placebo | Intervention Type: DRUG; Name: nemolizumab (CIM331); Assigned to Arm(s): Group1, Group2, Group3, Group4, Group5 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Group5
B: Arm Label: Placebo qw; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Other: Background treatment | Arm Label: Dupilumab 200 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Other: Background treatment | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 200 mg qw | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo qw | Intervention Type: OTHER; Name: Background treatment; Assigned to Arm(s): Dupilumab 200 mg qw, Placebo qw
C: Arm Label: Placebo qw; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Arm Label: Dupilumab 300 mg qw; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Arm Label: Dupilumab 300 mg q2w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 200 mg q2w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 300 mg q4w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Dupilumab 100 mg q4w; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Dupilumab 100 mg q4w, Dupilumab 200 mg q2w, Dupilumab 300 mg q2w, Dupilumab 300 mg q4w, Dupilumab 300 mg qw | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Dupilumab 100 mg q4w, Dupilumab 200 mg q2w, Dupilumab 300 mg q2w, Dupilumab 300 mg q4w, Placebo qw
D: Arm Label: 20 mg BID; Type: EXPERIMENTAL; Interventions: Drug: Apremilast | Arm Label: 30 mg BID; Type: EXPERIMENTAL; Interventions: Drug: Apremilast | Intervention Type: DRUG; Name: Apremilast; Assigned to Arm(s): 20 mg BID, 30 mg BID

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Depression Care Management Initiative in Home Healthcare
Brief Summary: Depression in older home healthcare patients occurs very often, is typically not treated appropriately, and leads to poor health outcomes. This study tests an intervention, called "Depression Care for Patients at Home" or the Depression CAREPATH, designed to help home healthcare nurses work with the patients, their family, and their doctors in managing depression treat depression according to clinical guidelines and to manage its treatment over time. Patient outcomes, measured at 3, 6, and 12 months, include guideline-consistent changes in depression treatment and reduction in depressive symptoms.


Options:
A: Arm Label: Depression CAREPATH; Type: EXPERIMENTAL; Interventions: Other: Depression CAREPATH | Arm Label: Usual Care; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Depression CAREPATH; Assigned to Arm(s): Depression CAREPATH | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Collaborative depression care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative depression care management | Intervention Type: BEHAVIORAL; Name: Collaborative depression care management; Assigned to Arm(s): Collaborative depression care
C: Arm Label: Assistance with Pain Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Assistance with Pain treatment | Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistance with Pain treatment; Assigned to Arm(s): Assistance with Pain Treatment
D: Arm Label: Arm 1 Telemedicine Outreach for PTSD; Type: EXPERIMENTAL; Interventions: Other: Telemedicine Outreach for PTSD | Arm Label: Arm 2 Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telemedicine Outreach for PTSD; Assigned to Arm(s): Arm 1 Telemedicine Outreach for PTSD

Answer: A